X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: KCL017; Von Hippel-Lindau Syndrome mutations
NIH Registration Number: 0217
NIH Approval Number: NIHhESC-13-0217
Available for Distribution: Yes
Provider Restrictions: The cells cannot be used for treatment purposes; this line carries mutations associated with Von Hippel-Lindau Syndrome.

NIH Restrictions: (No Additional Restrictions)
Additional Information: This line carries mutations associated with Von Hippel-Lindau Syndrome.

Submitting Organization: King's College London
Provider Name: Dusko Ilic, King's College London
Provider Phone: +44 20 7188 0547
Provider Email: dusko.ilic@kcl.ac.uk
Provider URL:  
Approval Date: 09/19/2013


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster